The effect of Gabapentin in traumatic brain injury

Phase 2

• Conditions: Diffuse brain injury.; Diffuse brain injury

• Registration Number: IRCT201009204786N1
• Lead Sponsor: Vice chancellery for research, Isfahan university of medical sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

The patients who suffered from moderate (9 <=GSC>12) and severe (GCS<9) traumatic brain injury and diffuse axonal injury were included.
The exclusion criteria were: the patient death during the study and the patients who did not tolerate gabepentin or present its severe side effects.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Glasgow Coma Scale. Timepoint: before intervention, 1 and 2 weeks after intervention onset, at the first outpatient referral. Method of measurement: Physical examination.;Glasgow outcome scale. Timepoint: before intervention, 1 and 2 weeks after intervention onset, at the first outpatient referral. Method of measurement: Physical examination.

Secondary Outcome Measures

Name	Time	Method
Electroencephalography. Timepoint: before intervention, 1 and 2 weeks after intervention onset, at the first outpatient referral. Method of measurement: Electroencephalography.